As the saying goes, if it looks too good to be true, it probably is.
For too long this industry has lagged the pharma sector in terms of using data analytics to predict market trends. It’s time to change that.
There are several critical questions that your internal team should be ready to address when preparing product portfolios and seeking out a CRO.
Here are the most read articles of the year.
Although many device companies are seeking cost savings when seeking sourcing products or components manufactured in Asia, quality should not be compromised. Intense due diligence is important.
With the heightened supplier scrutiny, it’s time to reevaluate your supplier quality program.
Managing suppliers is critical, and your processes in doing so must be documented.
Held in November, the COMPAMED and MEDICA trade fair will showcase futuristic as well as tried-and-true medical technologies.
Fewer resources and more requirements are hindering the process.
There’s no excuse. FDA really does make it easy.